Mural Oncology plc (MURA)
USD 3.19
(-5.9%)
USD 3.19
(-5.9%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -194.24 Million | -168.58 Million | -156.66 Million |
| Net Income | -207.44 Million | -189.8 Million | -175.43 Million |
| Depreciation & Amortization | 2.56 Million | 1.54 Million | 1.47 Million |
| Deferred income taxes | -29.24 Million | -15.01 Million | -14.45 Million |
| Stock-based compensation | 24.1 Million | 11.93 Million | 11.5 Million |
| Change in working capital | -13.47 Million | 7.74 Million | 5.78 Million |
| Other non-cash items | 29.24 Million | 15.01 Million | 14.45 Million |
| Investing Cash Flow | -3.45 Million | -5.51 Million | -4.38 Million |
| Investments in PPE | -3.45 Million | -5.51 Million | -4.38 Million |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | -3500.00 | - | - |
| Financing Cash Flow | 468.81 Million | 174.09 Million | 161.05 Million |
| Debt repayment | - | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | - | - | - |
| Other Financing Activities | 468.81 Million | 174.09 Million | 161.05 Million |
| Accounts receivables | - | - | - |
| Accounts payables | - | - | - |
| Inventory | - | - | - |
| Other working capital | -13.47 Million | 7.74 Million | 5.78 Million |
| Cash at beginning of period | - | - | - |
| Cash at end of period | 271.11 Million | - | - |
| Capital Expenditure | -3.45 Million | -5.51 Million | -4.38 Million |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 271.11 Million | - | - |
| Free Cash Flow | -197.7 Million | -174.09 Million | -161.05 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -31.56 Million | -30.91 Million | -207.44 Million | -59.53 Million | -51.28 Million | -50.16 Million |
| Depreciation & Amortization | 900 Thousand | 846 Thousand | 2.56 Million | 613 Thousand | 779 Thousand | 645 Thousand |
| Deferred income taxes | - | - | -29.24 Million | -16.45 Million | - | - |
| Stock-based compensation | 1.19 Million | 2.19 Million | 24.1 Million | 15.23 Million | 2.98 Million | 3.14 Million |
| Change in working capital | 2.48 Million | -9.46 Million | -13.47 Million | 966 Thousand | -2.95 Million | 1.06 Million |
| Other non-cash items | -270 Thousand | 238 Thousand | 29.24 Million | 16.45 Million | - | - |
| Investing Cash Flow | 43.68 Million | -124.54 Million | -3.45 Million | -1.17 Million | -1.16 Million | -710 Thousand |
| Investments in PPE | - | -55 Thousand | -3.45 Million | -1.17 Million | -1.16 Million | -710 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -19.31 Million | -124.48 Million | - | - | - | - |
| Sales/Maturities of investments | 63 Million | - | - | - | - | - |
| Other Investing Activities | 63 Million | - | -3500.00 | -3500.00 | - | - |
| Financing Cash Flow | - | - | 468.81 Million | 315.01 Million | 51.63 Million | 46.02 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 468.81 Million | 315.01 Million | 51.63 Million | 46.02 Million |
| Accounts receivables | 890 Thousand | 3.65 Million | - | - | - | - |
| Accounts payables | - | -7.92 Million | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.59 Million | -13.11 Million | -13.47 Million | 966 Thousand | - | - |
| Cash at beginning of period | 107.26 Million | 270.85 Million | - | - | - | - |
| Cash at end of period | 121.58 Million | 107.26 Million | 271.11 Million | 271.11 Million | - | - |
| Capital Expenditure | - | -55 Thousand | -3.45 Million | -1.17 Million | -1.16 Million | -710 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 14.32 Million | -163.58 Million | 271.11 Million | 271.11 Million | - | - |
| Free Cash Flow | -29.35 Million | -37.39 Million | -197.7 Million | -43.9 Million | -51.63 Million | -46.02 Million |
3470
3633
AMARIN
ZRFY
SGC
8064